GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (CHIX:PEGc) » Definitions » Shiller PE Ratio

Pharma Equity Group A/S (CHIX:PEGC) Shiller PE Ratio : (As of May. 13, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pharma Equity Group A/S Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharma Equity Group A/S Shiller PE Ratio Historical Data

The historical data trend for Pharma Equity Group A/S's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Shiller PE Ratio Chart

Pharma Equity Group A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pharma Equity Group A/S Quarterly Data
Mar16 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharma Equity Group A/S's Shiller PE Ratio

For the Biotechnology subindustry, Pharma Equity Group A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Equity Group A/S's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group A/S's Shiller PE Ratio falls into.



Pharma Equity Group A/S Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pharma Equity Group A/S's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Pharma Equity Group A/S's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.01/116.7000*116.7000
=-0.010

Current CPI (Dec. 2023) = 116.7000.

Pharma Equity Group A/S Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201103 -3.375 95.800 -4.111
201106 -2.275 96.100 -2.763
201109 -2.015 96.300 -2.442
201112 -5.655 96.300 -6.853
201203 -1.935 98.300 -2.297
201206 -3.330 98.200 -3.957
201209 -2.885 98.700 -3.411
201212 -20.405 98.300 -24.224
201303 -2.835 99.300 -3.332
201306 -41.965 99.100 -49.418
201309 -4.390 99.200 -5.164
201312 -44.150 99.000 -52.043
201403 -2.180 99.600 -2.554
201406 -0.905 99.700 -1.059
201409 -0.005 99.700 -0.006
201412 -2.735 99.400 -3.211
201503 -0.150 100.200 -0.175
201506 -0.200 100.300 -0.233
201509 -0.040 100.200 -0.047
201512 -0.055 99.800 -0.064
201603 -0.017 100.200 -0.020
201606 -0.010 100.600 -0.012
201612 -0.023 100.300 -0.027
201706 -0.009 101.200 -0.010
201712 0.015 101.300 0.017
201806 0.100 102.300 0.114
201812 -0.400 102.100 -0.457
201906 -0.150 102.900 -0.170
201912 -0.550 102.900 -0.624
202006 -0.075 103.200 -0.085
202012 -0.648 103.400 -0.731
202106 -0.020 105.000 -0.022
202112 0.162 106.600 0.177
202206 0.040 113.600 0.041
202209 -0.002 116.400 -0.002
202212 0.000 115.900 0.000
202303 -0.150 117.300 -0.149
202306 -0.004 116.400 -0.004
202309 -0.004 117.400 -0.004
202312 -0.010 116.700 -0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharma Equity Group A/S  (CHIX:PEGc) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pharma Equity Group A/S Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Equity Group A/S (CHIX:PEGC) Business Description

Traded in Other Exchanges
Address
Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970
Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.

Pharma Equity Group A/S (CHIX:PEGC) Headlines

No Headlines